ProCE Banner Activity

Smoldering Myeloma: Determining Risk of Progression and Considerations for Therapy

Slideset Download
Download these slides from a live symposium for an overview of considerations for risk assessment and treatment of smoldering myeloma therapy.

Released: December 09, 2022

Expiration: December 08, 2023

No longer available for credit.

Share

Faculty

Jesus San-Miguel

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Janssen administered by Scientific Affairs

Karyopharm Therapeutics Inc.

Pfizer, Inc.

Regeneron Pharmaceuticals, Inc.

Takeda Pharm USA

Partners

International Myeloma Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain